HEALEY ALS Platform Trial - Regimen G DNL343

Summary

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen G will evaluate the safety and efficacy of a single study drug, DNL343, in participants with ALS.

Timeline

Start

2023-05-24

Primary completion

2024-10-29

Completion

2024-10-29

Drugs

Indications